Johannes Stanta

Johannes Stanta's work experience includes several roles in the field of molecular and cellular biology. Johannes is currently the Global Director of Molecular and Cellular Biology at Celerion, starting in October 2022. Prior to this, they worked at Freeline as the Director of Bioanalysis (Gene Therapy) from January 2021 to July 2022. In this role, they were responsible for establishing and maintaining a GCP regulated bioanalytical capability and infrastructure, building a high-performing internal Bioanalytical team, and leading the development of a companion diagnostic assay.

Before joining Freeline, Johannes worked at Covance from 2014 to 2021. Johannes held multiple positions including Senior Scientific Manager and Method Development Manager. In these roles, they directed and oversaw bioanalytical studies to support drug development, managed scientific staff, and provided scientific and regulatory direction for biomarker and quantitative bioanalytical methods developments.

Prior to Covance, Johannes was the Head of Laboratory Services at Hammersmith Medicines Research Ltd from 2011 to 2014. Johannes led and managed an accredited pathology and biomarker laboratory, provided scientific and regulatory leadership, and oversaw a team of scientific staff and managers.

Earlier in their career, Johannes served as a Director at FC Business Intelligence Ltd from 2009 to 2011. Johannes also worked as a Research Scientist at the University of Cambridge, focusing on biomarker discovery for schizophrenia, and as a DOC Research Fellow at the Austrian Academy of Science.

Overall, Johannes Stanta has extensive experience in molecular and cellular biology, bioanalysis, laboratory management, and scientific leadership.

Johannes Stanta's education history begins with their Erasmus Scholarship at The University of Sheffield in 2003, where they focused on Chemistry and Biochemistry. Johannes then pursued a degree in Chemistry, Biochemistry, and Biotechnology at Technische Universität Graz, completing their diploma in 2005, which is equivalent to a BSc and MSc. Johannes went on to attend the University of Cambridge, earning their PhD in Biotechnology in 2008. Johannes later obtained a certification as a Radiation Protection Supervisor from King's College Hospital and Guy's & St. Thomas' NHS Foundation Trust in June 2013. Additional information about Johannes Stanta's education is not provided.